Show Summary Details
Page of

Restless Legs Syndrome 

Restless Legs Syndrome
Restless Legs Syndrome

Roger M. Kurlan

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 25 July 2021

Restless legs syndrome is characterized by uncomfortable feelings in the legs associated with an urge to move the legs in order to seek relief. Symptoms typically begin soon after lying down for sleep. The main disability is interference with sleep. Many patients have periodic movements of sleep, involuntary flexion jerks, and spasms of the legs. The disorder is thought to be related to impaired brain dopaminergic neurotransmission, although some evidence suggests an abnormality of the endogenous opioid system. There is a strong genetic influence, and some gene loci linked to the condition have been identified. Restless legs syndrome is associated with certain medical conditions, including anemia, iron deficiency, chronic renal failure/renal dialysis, pregnancy, lumbar spine disease, and Parkinson’s disease. Tolerance is a common problem with pharmacotherapy for restless legs syndrome, and augmentation can be a major complication, particularly with dopaminergic therapy.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.